Octomera

Octomera is a forward-thinking pharmaceutical manufacturing company focused on evolving cell and gene therapy (CGT) production through a decentralized approach. Octomera enables point-of-care cell and gene therapy (CGT) production with comprehensive support services and adaptable capacity, utilizing agnostic OMPULS (Octomera Mobile Processing Units & Labs).

At Octomera, the commitment to quality management, regulatory compliance, and scalable production drives its mission to advance GMP commercialization and process development. The company's innovative solutions are designed to meet the evolving needs of the biopharmaceutical industry, ensuring efficient and reliable CGT production. Octomera is dedicated to pushing the boundaries of pharmaceutical manufacturing and improving patient outcomes through groundbreaking therapies.

The team at Octomera is constantly striving to enhance its offerings and expand its capabilities within the pharmaceutical sector. Further details about Octomera’s specific advancements and expanded service offerings will be completed soon with the support of the company’s management.

To the manager of Octomera, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight Octomera's unique contributions to the pharmaceutical industry.